Jeff Brenner – final meeting

Met with Jeff Brenner, Medical Director at Camden Coalition of Healthcare Providers.

Learned about him after listening to these freakonomics podcasts:

link

link

An eloquent, thoughtful keen student of the history of epidemiology, public health’s political success and a tireless advocate for the underserved communities of Camden, NJ.

Holds a strong, long-term, systems view of change in public health and healthcare.

Currently engaged in a loss-avoidance play as an ACO demonstration site – geographically defined, shared savings project, which has protection from federal anti-trust laws to allow providers to collaborate.

Doubts the claims of most preventive health organisations, on basis of the Medicare Chronic Care Demonstration Project in the 80s where only 3 of 15 corporate participants survived a randomised control trial of preventive interventions after a year.

The game changer in many examples of public health shift are the troubling personal experiences of decision makers.

Emotional, visceral, aesthetic impact.

Tapped into Grenny’s observation about Don Berwick needing to get hospital CEOs to run the analysis of patient harm personally rather than to delegate in order to experience first hand the damage their institutions were doing to their patients.

Examples of AU Health Minister’s personal experience of the harms of tobacco driving the change to plain packaging.

Complex systems are kept in place by:

  • goodwill
  • money
  • tax dollars
  • positive media
  • These foundations need to be eroded one by one to effect change.

For a venture capitalist, they’ll need a pitch that appeals to their outrage at the lack of evidence or transparency around the way that healthcare works.

For someone on the left, the conversation will need to be nuanced around the human tragedy of chronic disease, and the need for humanity to do better.

Don’t get wedded to the strategy, just the outcome.

There is a 100 year gulf between the way corporations collect and use data, and the way that government uses the same resource.

Analytics allow us to surveil, segment, target and measure interventions, then tell a good story of why things happen.

Dual System Utilizers – healthcare and law enforcement

On the way to the meeting, came up with a name for the concept – the QALYBOND – will grab the domain name.

References

http://www.macfound.org/fellows/886/

  1. “Bury the Chains” – end of slavery
  1. “The Children” – civils rights movement
  1. The fight to roll out covered sewers, welfare reform (fixed by the right)
  1. Adverse Childhood Event Study – Vince Felitti, KP

Health Evolution Summit – Overview

 

http://www.healthevolutionsummit.com/Default.aspx?PageID=16199729

1:00 pm – 2:15 pm

Pre-Summit Sessions (concurrent)

CEOs of leading providers/payers share their outlook on their critical innovation priorities and highlight respective approaches to vet solutions. A variety of provider/payer executives then connect with innovative CEOs from relevant service, IT and product companies to learn about new solutions and provide insights on the solutions’ value to the market.

Pavillions IV & V

Payer Connect: Where payer executives and innovative CEOs meet

Select health plan CEOs will share their strategic forecasts and the critical innovations necessary to remain competitive in a dynamic market. Payer executives and CEOs of relevant health service, IT and product companies will network briefly to share ideas and make a plan to reconnect pending mutual benefit.

Moderator:
Mike Gaffney, Co-Founder and Managing Director, EDG Partners

Speakers:
Dan Hilferty, President and CEO, Independence Blue Cross
Steve S. Martin, President and CEO, Blue Cross and Blue Shield of Nebraska, Summit Chair

Networking tables will be hosted by:
Aetna – Bjorn Thaler, VP, Head of Corporate Development
Blue Cross & Blue Shield of Nebraska – Steve S. Martin, CEO and Lew Trowbridge, President and Chief Operating Officer
Blue Cross & Blue Shield of North Carolina – Andy Brynes, VP, Strategic Development, Mosaic Health Solutions
Cambia Health Solutions – Ben Albert, Operating Partner, Rob Coppedge, SVP Strategic Investment & Corporate Development
Highmark Health – Nanette DeTurk, EVP, Chief Administrative and Strategy Officer and Treasurer
Independence Blue Cross – Terry Booker, VP of Corporate Development and Innovation, and Tom Olenzak, Managing Director Strategic Innovation Portfolio

Salons I & II

Provider Connect: Where provider executives and innovative CEOs meet

Select provider CEOs will share their strategic forecasts and the critical innovations necessary for their organizations to remain relevant and competitive. Provider executives and CEOs of relevant health service, IT and product companies will briefly network to share ideas and make a plan to reconnect pending mutual benefit.

Moderator:
Robert Wah, MD, Chief Medical Officer, CSC; President, AMA

Speakers:
John Brooks, President and CEO, Joslin Diabetes Center
John D. Doyle, President and CEO, Ascension Holdings
Michael Wagner, MD, FACP, President and CEO, Tufts Medical Center

Networking tables will be hosted by:
Dignity Health – Richard Roth, Chief Strategic Innovation Officer
Hospital Corporation of America – Chip Blaufuss, AVP of Strategic Innovation
Kaiser Permanente – Chris Stenzel, VP of Business Development and Innovation
Stanford Health Care – Kash Kapadia, VP and General Manager, Digital Health
Sutter Health – Peter Anderson, Chief Strategy Officer
Swedish Medical Group – Ralph Pascualy, Chief Executive

2:15 pm – 3:15 pm
The Monarch Bay Sunset Terrace

Alumni Reception

Before the Summit begins, relax and reconnect with fellow alumni. All Summit alumni welcome to attend.

2:15 pm – 3:15 pm
Monarch Pool Terrace

First-Time Participant Welcome

Meet fellow first-time Summit participants. All first-time Summit participants welcome.

General Session: Emerging (and Decaying) Models

The Summit explores the macro implications of emerging (and decaying) models in health and the micro implications that flow from them through a lens that cuts across traditional industry lines of health care services, health IT and life science. Sessions explore the economic underbelly of big issues in search of sustainable business models, directional opportunities and Beachheads.

3:30 pm – 3:45 pm
Salons III & IV

Opening Comments

Patrick Geraghty, Chairman and CEO, GuideWell and Florida Blue, Summit Chair
Ann H. Lamont, Managing Partner, Oak HC/FT Partners, Summit Innovation Chair
Charlie Martin, Chairman and CEO, Martin Ventures
Julie Murchinson, CEO, Health Evolution Summit

3:45 pm – 4:30 pm
Salons III & IV

A Perspective with Steve Hemsley

Interviewer:
Todd Cozzens, Partner, Sequoia Capital, Summit Innovation Chair

Speaker:
Steve Hemsley, CEO, UnitedHealth Group

Building the Business Case for High-Priced Therapeutics

Specialty drugs in the U.S. now comprise more than 25% of total pharmaceutical spend and the annual cost per patient can be as high as $100,000 per year. By 2020, the cost of specialty drugs is projected to quadruple and cost the nation more than $400 billion. Is the high-priced approach the new business model for innovation? Are there economically rational reimbursement approaches for certain high-costs diseases? Leaders with high stakes in the game will explore these trade-offs, emerging approaches and financing mechanisms.

Moderator:
Arnold Milstein, MD, MPH, Professor of Medicine, Director of Clinical Excellence Research Center, Stanford University

Speakers:
Joshua Ofman, MD, MSHS, SVP, Global Value and Access and Policy, Amgen
Tim Wentworth, President, Express Scripts

5:20 pm – 6:00 pm
Salons III & IV

The Consumer-Engaged Enterprise

To both attract and retain customers, even the most well-established, integrated delivery networks are striving to re-engineer their approach to consumer-centric convenience and service. Meanwhile, newer companies are striving to demonstrate an entirely new level of consumer experience with tools and delivery models that speak to consumer interests. Hear from an established integrated delivery system and a novel primary care model on what is working and where they are headed.

Moderator:
Brad Fluegel, Chief Strategy and Business, Development Officer, Walgreens Boots Alliance,Summit Partner Committee

Speakers:
Rushika Fernandopulle, MD, MPP, CEO and Co-Founder, Iora Health
Glenn D. Steele Jr., MD, PhD, President and CEO, Geisinger Health System

6:00 pm – 9:00 pm
Dana Lawn

Welcome Event

Dinner served

9:00 pm – 11:00 pm
The Terrace Salon Balcony

Après Dessert and Digestifs

 

APRIL
30
THURSDAY
6:00 am – 7:00 am
The Gazebo

Morning Fitness Boost

Summit Run, hosted by HealthLine

7:00 am – 6:00 pm
Salon Foyer

Registration Open

7:00 am – 8:00 am
The Monarch Bay Courtyard

Breakfast

7:00 am – 8:00 am
Salon I

Breakfast Session

Profitable Innovation: Invention, Commercialization, Execution
Facilitated by Dentons

Facilitated by: Bruce Fried, Partner, Dentons with panelists: Ronald Kuerbitz, CEO, Fresenius Medical Care North America and Ed Dougherty, Principal, Dentons

Senior executives in every sector of the industry are charged with delivering value. Some need to shorten time to market, others need to produce near term ROI, and others still need to deliver quality healthcare services and improve treatment outcomes in an increasingly price-sensitive environment.

On the eve of the Kentucky Derby, we award the ‘Triple Crown’ to healthcare executives, whose success depends on winning multiple races: being responsive to investors, compliant with regulators and innovators, and delivering affordable, high quality products and services for providers and patients. This session will discuss keys to winning the healthcare triple crown including a baseline model, synthesizing the global clinical and business literature, and testing this model against panelist and audience experience and expertise. Participants will leave with a framework within which to test concepts presented throughout the Summit against the real opportunities and constraints of the business of healthcare.

– Description

General Session: Emerging (and Decaying) Models

8:00 am – 9:00 am
Salons III & IV

The CMS Perspective: Where Do We Go From Here?

Interviewer:
Bruce Bodaken, Visiting Scholar, Brookings Institution and former Chairman and CEO, Blue Shield of California, Summit Chair

Speaker:
Andy Slavitt, Acting Administrator, Centers for Medicare & Medicaid

The Real Deal: Taking on High-Cost, Complex Patients at Scale

Despite challenges, we are seeing an incredible wave of new solutions in caring for populations with multiple chronic diseases, more significant behavioral health issues and complex social situations. Many suspect these solutions will have even more opportunities ahead as they transform individual care. Hear payer, investor and innovator perspectives on what can really be achieved and what new opportunities have yet to be tackled.

Introducer:
Guy Eiferman, Senior Vice President, Strategic Planning and Managing Director, Healthcare Services and Solutions, Merck

Moderator:
Mark D. Smith, MD, MBA, Founding President, California HealthCare Foundation, Summit Chair

Speakers:
Adam Boehler, CEO, Landmark Health
Jay M. Gellert, President and CEO, Health Net, Inc.
Leeba Lessin, President and CEO, CareMore Health System
Thomas A. Scully, General Partner, Welsh, Carson, Anderson & Stowe

10:00 am – 10:30 am
The Monarch Bay Courtyard

Morning Break

10:30 am – 11:20 am
Salons III & IV

Size Matters: New Approaches to National Provider Brands

Even the most notable regional systems face a growth dilemma, causing some to explore innovative approaches to national expansion, unburdened by brick-and-mortar models.  Cleveland Clinic and DaVita HealthCare Partners are on the forefront of these efforts, and others are not far behind.  How are best-of-breed providers thinking about scale, how are they ensuring quality and how will they avoid obstacles seen in past waves?

Introducer:
Kris Joshi, PhD, Executive VP, Products, Emdeon

Moderator:
Michael E. Chernew, PhD, Leonard D. Schaeffer Professor of Health Care Policy and Director, Healthcare Markets and Regulation Lab, Harvard Medical School

Speakers:
Toby Cosgrove, MD, President and CEO, Cleveland Clinic
Kent Thiry, Co-Chairman and CEO, DaVita HealthCare Partners

11:30 am – 12:30 pm

Deep Dive Sessions

Salons II
What the Consumer Really Wants: Data Insights into Purchasing Behavior
Hosted by Aon

Facilitated by Matt Levin, EVP and Head of Global Strategy, Aon and Janet Faircloth, SVP, Strategy and Solutions, Aon

+ Description

Pavilion I
Big Brains on the Internet of Things (IoT)
Hosted by Box

Facilitated by Aneesh Chopra, former CTO, White House, President Obama with panelists: Aaron Levie, CEO, Box; Lee Shapiro, former President, Allscripts and Bill Russell, CIO, St. Joseph Health System

+ Description

Salon I
Transparency of Cost and Quality: Changing Consumer Behavior at Scale?
Hosted by Emdeon

Facilitated by Doug Ghertner, President, Change Healthcare and Jason Gorevic, CEO, Teladoc

+ Description

The Plaza
The Next Holy Grail: Strategic Cost Control
Hosted by Healthagen

Facilitated by Charles Kennedy, MD, Chief Population Health Officer, Healthagen

+ Description

12:30 pm – 2:00 pm
The Monarch Bay Courtyard

Lunch

Topic Tables

+ Description

2:00 pm – 2:50 pm
Salons III & IV

Harnessing the Reality of End-of-Life

End-of-life care accounted for over 28% of Medicare’s budget—or $170B spent in the last six months of life for Medicare beneficiaries alone. According to the Institute of Medicine, enhancing the quality of medical and social services at the end of life would create substantial progress toward a sustainable U.S. health care system. Now more than ever, end-of-life services are becoming a strategic industry priority. Two prominent payers and a health system leader will discuss the most critical issues, where best economics are emerging and potential models for advancing management of end-of-life care.

Moderator:
Alexandra Drane, Co-Founder and Chair of the Board, Eliza Corporation; Co-Founder, Engage with Grace

Speakers:
Mark B. Ganz, President and CEO, Cambia Health Solutions, Summit Chair
Wright R. Lassiter, III, President, Henry Ford Health System
Harold L. Paz, MD, MS, EVP and Chief Medical Officer, Aetna

3:00 pm – 4:00 pm

Deep Dive Sessions

Busting Myths about the 50+: Tracking that Works
Hosted by AARP

Facilitated by Jody Holtzman, SVP Thought Leadership, AARP, with presenter Brad Fain, Principal Research Scientist, Head of the Human Systems Engineering Branch, Georgia Tech Research Institute and panelist Julio Corredor, Director, Worldwide Innovation

+ Description

Salon I

The Complexities of Patient Financial Responsibility
Hosted by Availity

Facilitated by Russ Thomas, CEO, Availity with panelists; Alan Levine, CEO, Mountain States Health Alliance, Rob Coppedge, SVP Strategic Investment and Corporate Development, Cambia Health Solutions, and Sam Khashman, President and CEO, Imagine Software

+ Description

The Plaza
Agile Health – New Models of Care Need New Models of IT
Hosted by CSC

Facilitated by Robert Wah, MD, Chief Medical Officer, CSC, and President of the AMA and Lisa Pettigrew, Industry General Manager, Global Healthcare, CSC

+ Description

Salon II
Zip Code-Driven Health Insights…More Informative than Genetic Code?
Hosted by Optum

Facilitated by Paul Bleicher, MD, PhD, CEO, Optum Labs, and Dave Dickinson, Chief Innovation Officer, Optum Labs

+ Description

4:00 pm – 6:00 pm
The Monarch Bay Courtyard

Afternoon Break

4:15 pm – 5:15 pm
The Terrace Salon

Confab of Women Building Impactful Companies

Join an unmoderated discussion among female healthcare leaders focused on what it takes to build strong teams, how to bring out the best “male” and “female” traits, what “female” traits provide distinct advantages, and what women are getting it done and why.

Speakers:
Gail Boudreaux, Former CEO, UnitedHealthcare
Alexandra Drane, Co-Founder and Chair of the Board, Eliza Corporation; Co-Founder, Engage with Grace
Ann H. Lamont, Managing Partner, Oak HC/FT Partners, Summit Innovation Chair
Lisa Suennen, Managing Partner, Venture Valkyr

6:00 pm – 7:00 pm
Pacific Promenade Lawn

Global Health Reception

7:00 pm – 9:00 pm
The Pacific Promenade

The Big Dinner
Global Disease: How New Investment Priorities Are Changing the Landscape

As the Bill & Melinda Gates Foundation works with its partners to transform lives in developing countries, they are acutely focused on tapping into the talent and resources of the private sector. If Ebola taught us anything, low-cost, sustainable solutions need to be created and delivered to ensure not only local and global health, but also economic viability for all. Enter stage left…opportunity. Sue Desmond-Hellmann will share the business case for the global frontier.

Introducer:
Robert Margolis, MD, CEO Emeritus, HealthCare Partners, Summit Chair

Interviewer:
David Brailer, MD, PhD, Managing Partner and CEO, Health Evolution Partners; Chairman, Health Evolution Summit

Speaker:
Sue Desmond-Hellmann, MD, CEO, Bill & Melinda Gates Foundation

9:00 pm – 11:00 pm
The Plaza

Après

Blackjack and poker overlooking the Pacific.

 

MAY
01
FRIDAY
6:00 am – 7:00 am
The Gazebo

Morning Fitness Boost

Summit Boot Camp

7:00 am – 12:00 pm
Salon Foyer

Registration Open

7:00 am – 8:00 am
The Monarch Bay Courtyard

Breakfast

General Session: Disruptive Models

Disruption is happening in pockets, at varying paces and in a variety of ways. In 2015, the Summit explores where new innovations are seeing landfall and the army of others just behind.

8:00 am – 9:00 am
Salons III & IV

Moon Shots on Health

Moon Shots – big thinking and aiming for breakthroughs instead of incremental improvements – this is the Google[x] mandate. Google has disrupted just about everything we can think of, so what are they up to in health? Will they be the creator or a potential competitor? The former head of the largest health plan in the country shares her perspectives on moon shots…potential profiles, obstacles and how the practical realities of the past may be shifting. Together, this session will raise the stakes and foreshadow areas where we see breakthroughs instead of barriers.

Moderator:
Peter Neupert, Operating Partner, Health Evolution Partners and Former Corporate VP, Microsoft Health Solutions Group, Summit Chair

Speakers:
Gail Boudreaux, Former CEO, UnitedHealthcare
Andy Conrad, PhD, Head of Life Sciences, Google

9:00 am – 9:30 am
Salons III & IV

Consumer On Ramps – Disruptive Models Creating Value

As health care endeavors to engage consumers in their health, some companies are also beginning to create efficiencies, support evolving reimbursement streams and position for value creation. From searching for health information to being monitored remotely; from the healthy consumer to those managing chronic disease or facing acute conditions—the early adopters are contributing to the new health economy. This session will highlight a few innovators disrupting information flow and creating value through the holy grail of the consumer engagement.

Moderator:
Brandon H. Hull, Managing General Partner, Cardinal Partners, Summit Innovation Chair

Speakers:
Eric Rock, CEO, Vivify Health
Ben Wolin, CEO and Co-Founder, Everyday Health

9:30 am – 10:25 am
Salons III & IV

Corporate Venture Takes Hold of Health Care

Creating a corporate venture group is certainly one of the hippest strategies to hit the health industry in years. And while these ventures all hope to capitalize on the next biggest disruption to hit the market, they will not all look the same in their pursuits. Hear what disruptive models are on the horizon, what factors are being considered and what you can expect.

Introducer:
Mark Speers, Partner and Managing Director, Health Advances, LLC

Moderator:
Lisa Suennen, Managing Partner, Venture Valkyrie

Speakers:
Rob Coppedge, SVP Strategic Investment and Corporate Development, Cambia Health Solutions
Dave Schulte, Managing Director, Kaiser Permanente Ventures
David Stevenson, Managing Director, Global Health Innovation Fund, Merck
Rafael Torres, Head of Healthcare, GE Ventures

10:25 am – 10:30 am
Salons III & IV

Comments and Transition to Innovation Activities

Julie Murchinson, CEO, Health Evolution Summit

10:45 am – 1:00 pm
The Plaza

Corporate Venture Action Group

Innovation Activities (concurrent)

Innovators and health leaders roll up their sleeves in an intimate and interactive setting to explore opportunities.

10:40 am – 11:40 am
Salon I

Innovations with Traction: Straight Talk from Customer CEOs

Patient retention and new patient acquisition have always been strategic imperatives, but their importance has risen to mission critical in the transition from fee-for-service to fee-for-value. While these areas may have great impact on both risk of lost revenue and new growth opportunities, they have not been easy problems to solve—and several innovative solutions have stalled. A leading health system CEO talks with innovators about the range of challenges health systems are facing, the approach that different companies are taking and the successes that organizations are experiencing to ensure true value is realized.

Facilitator:
Roy Smythe, MD, Chief Medical Officer, AVIA

Speaker:
Rodney F. Hochman, MD, President and CEO, Providence Health & Services

Innovators:
Mark Hefner, CEO, Infina Connect Healthcare Systems
Oran Muduroglu, CEO, Medicalis

10:40 am – 11:40 am
Pavilion II

Disruption in Progress: Designing for the Consumer

Innovators and health care leaders on the consumer front lines retreat to the boardroom to explore how best to design for the consumer. Innovators are encouraged to roll up their sleeves in this intimate discussion exploring critical needs, while potential payer, provider and retailer customers help to inform design and their approach.

Facilitator:
Joshua Riff, SVP, Consumer Products, Optum

Contributors:
Rushika Fernandopulle, MD, MPP, CEO and Co-Founder, Iora Health
Jeffrey Kang, SVP, Health and Wellness, Services and Solutions, Walgreens Boots Alliance
Tej Shah, SVP, Business Development, Blue Cross Blue Shield of Louisiana

10:40 am – 11:40 am
Pavilion III

Disruption in Progress: Where Life Science Is Headed:
Opportunities Beyond the Pill

Innovators and life science leaders retreat to the boardroom to explore new opportunities beyond the pill. Innovators are encouraged to roll up their sleeves in this intimate discussion exploring critical needs, while potential pharma, biotech and medical device customers inform their solutions and their approach.

Facilitator:
Naomi Fried, PhD, VP of Innovation, Medical Information and External Partnerships, Biogenidec

Contributors:
Guy Eiferman, SVP, Strategic Planning and Managing Director, Healthcare Services and Solutions, Merck
Diego Miralles, MD, Global Head of Innovation, Janssen Pharmaceuticals, Johnson & Johnson
Pascale Witz, EVP, Global Divisions and Strategic Development, Sanofi

11:45 am – 12:45 pm
Pavilion IV

Disruption in Progress: Care Delivery Innovation

Innovators and health care leaders on the front lines of care delivery retreat to the boardroom to explore how to best to design solutions to improve care and reduce cost of delivery. Innovators are encouraged to roll up their sleeves in this intimate discussion exploring critical needs, while provider executives share the value they are seeking and how potential solutions are vetted behind closed doors.

Facilitator:
Molly Coye, MD, Chief Innovation Officer, UCLA Health System

Contributors:
Lyle Berkowitz, MD, FACP, FHIMSS, Associate Chief Medical Officer of Innovation, Northwestern Memorial Hospital
Chip Blaufuss, Assistant VP Strategic Innovation, Hospital Corporation of America
Birthe Dinesen, Professor, Department of Health Science and Technology, Aalborg University (Denmark)
Chuck Dowling, CEO, DiabetesAmerica

11:45 am – 12:45 pm
Pavilion V

Disruption in Progress: Connecting with Capital

Innovators and seasoned investors retreat to the boardroom to connect on the capital landscape: opportunities on the horizon, what investors are seeking, and what they may require in the coming years. Innovators are encouraged to roll up their sleeves in this intimate discussion to ask their burning questions and to hear from the veterans.

Facilitator:
Jodie Emery, Partner Healthcare and Private Equity, Caldwell Partners

Contributors:
Thomas Carella, Managing Director, Merchant Banking Division, Goldman Sachs
Brandon H. Hull, Managing General Partner, Cardinal Partners, Summit Innovation Chair
Noah Knauf, Managing Director, Warburg Pincus
Ravi Sachdev, Partner, Clayton, Dubilier & Rice

Meeting: Dr Shantanu Agarwal, CMS

Met with Dr Shantanu Agarwal, Deputy Administrator and Director, Center for Program Integrity

Excellent discussion comparing notes on system integrity in Australia and US.

CMS overall pays $1 trillion in program payments annually.

Point estimate is that 12% are improper payments – $48-52B per year.

The observation was made that FFS schedules like MBS were more than administrative tools, but effectively were clinical guidelines given the powerful incentives that they provide for particular treatments.

Analytic methods have been set and maturing for the last 5 years.

Most challenging element is how to close loop on anomalous behaviour:

  • Start with on-boarding/educating newly enrolled clinicians (prevention) using videos, literature, data, feedback.
  • Engagement with providers needs to be longitudinal, long term, personal, especially around low value care.
  • You need a credible (peer matched) messenger and data needs to be properly presented and matched.

This Health Affairs article describes a typical journey for a system Shantanu used to work for – ChenMed in Miami.

Discussed:

  • Fraud > Abuse > Waste > Error continuum
  • The agile human adversary
  • Chasing value slide
  • Gamma scoring methodologies
  • Choosing wisely > disinvestment
  • Surgeon dashboard
  • Surgeon selector

Shantanu mentioned that http://www.healthcostinstitute.org/ were seeking to build out similar statistical presentations to our own, but had so far only developed cost-oriented metrix with no dimension for quality/experience etc.

Other references for the meeting:

Reducing Medicare and Medicaid Fraud and Abuse – interview

Statement to Committee on Energy and Commerce
Subcommittee on Oversight & Investigations
United States House of Representatives  on Medicare Program Integrity: Screening Out Errors, Fraud and Abuse

Powerpoint: 764496_slide_CMS_DrShantanuAgrawal

 

cms

Meeting at National Health Care Anti-Fraud Association

Met with Lou Saccoccio (CEO) and Erin Carlson (Snr Director, Education and Training).

Excellent discussion regarding approaches taken to collaboration and partnership against fraud in US health care.

NHCAA are a small (12 FTEs) government and industry funded group (85 members) established in 1985 that supports a range of collaborative and educational programs including certification of fraud investigators – Accredited Health Care Fraud Investigator (AHFI) and Annual Training Conference.

Bupa are involved, mostly out of UK but also Australia (Michael Douman).

Ray Collins is very active in the space.

  • SIRIS is an information sharing/case management data base hosted by LexisNexis – contract regarding use to be forwarded. Sharing this information is legal provided it is performed according to strict guidelines and relates specifically to fraud investigation. It cannot be a fishing exercise. Cases must be built on own information, but having the database allows investigators to follow up with other investigators looking at a specific concern.
  • A number of firms provide a recoveries service offering – Verisk, Emdeon, LexisNexis – the standard charge is 30% commission on recoveries made.
  • Case discussion roundtable meetings support information sharing around specific cases.
  • Discussed the 7:1 ROI enjoyed by federal programs – much of this is returned by cases focused on recovering monies from “Pharmaceutical Off-label Marketing Fraud” and “Pharmaceutical Best Pricing Fraud” which then boosts overall figures.
  • Other approaches include cross-matching for recently deceased providers (phantom providers) who continue to bill. When this practice becomes endemic in a region, moratoria are established that prevent new providers being registered in that region.
  • Also look at “high cost pharmacies”, perform site visits and follow up on outliers on risk scoring.
  • MITRE Corporation (originally a military technology R&D organisation akin to RAND) are now collaborating with CMS in a program called CMS Alliance to Modernize Healthcare. Thier operating model involves partnership with government agencies on a sole source basis. IP can be captured by MITRE and then commercialised as required.
  • All Claims Pooling is another approach using trusted third parties – Verisk, Emdeon and LexisNexis.
  • Federally-granted Recovery Audit Contracts see third parties (e.g. Performant) chase potential recoveries from providers – not appreciated by providers.
  • Palantir had previously engaged with NHCAA but had since withdrawn. They have a contract with Aetna, but no one else in health was mentioned. Government entities tended to work solely with MITRE.
  • NHCAA saw much opportunity to extend scope from fraud to low value care – clinical special investigation units are involved in this work, typically headed by MDs and they meet at the annual conference.
  • Suggested engaging with CMS Head Dr Shantanu Agrawal who I am meeting on Wednesday.

Actions

  • Erin: refer me to Allanna Lovell at MITRE for a meeting
  • Erin: invite to anti-fraud conference in November
  • Erin: share guidelines for intelligence sharing

Linked and  attached are presentations by Shantanu Agrawal  and his staff on the CMS (Centers for Medicare & Medicaid Services) scoring system they are using, as well as their latest anti-fraud initiatives.